World

French parliament passes special law to ensure state funding pending 2026 budget

Dec 24, 2025

Paris [France], December 24: Lawmakers in France's National Assembly and Senate on Tuesday adopted a "special law" proposed by the government to extend the 2025 budget into next year, before resuming work on a final 2026 budget in January.
The move followed the failure of a joint committee of lawmakers from the National Assembly and the Senate on Dec. 19 to reach a compromise on the country's 2026 state budget, raising the prospect that France would enter the new year without a fully adopted budget.
Prime Minister Sebastien Lecornu had earlier said that the government would not resort to Article 49.3 of the Constitution, which allows legislation to be adopted without a parliamentary vote and has been used in previous years to push budgets through a divided parliament.
Lecornu, speaking on Tuesday evening at Matignon, the French prime minister's office, stressed that France must have a state budget in place in January, while reiterating the government's objective of reducing the public deficit to below 5 percent of gross domestic product in 2026.
France, the eurozone's second-largest economy, is under pressure to rein in its deficit and soaring debt, but efforts have been hampered by a political deadlock.
Source: Xinhua News Agency

More news

Sirolimus-Coated Balloon Matches Drug-Eluting Stent at One Year in Large International TRANSFORM II Trial

Tampa (Florida) [US], November 2: Sirolimus-coated balloon (SCB) strategy was non-inferior to contemporary everolimus-eluting stents (EES) for Target Lesion Failure (TLF) at 12 months in patients with de novo coronary artery disease. These are the results of the TRANSFORM II randomised trial, presented today as a Late-Breaking Clinical Trial at TCT 2026 and accepted in The Lancet which confirm how MagicTouch Sirolimus Coated Balloon (Concept Medical) matches contemporary best in class stent. Late-breaking results presented at TCT 2026 show an implant-free strategy with MagicTouch Sirolimus Coated Balloon is non-inferior to everolimus-eluting in de novo coronary artery disease.

Nov 02, 2026